TelePeptide Semaglutide Review
TelePep, TelePeptide LLC, telepeptide.org
Also spelled as TelePep, TelePeptide LLC, telepeptide.org — Same brand, same great service!
Our investigation of Compounded Semaglutide from TelePeptide
$89-$249/month all-inclusive — clinician, medication and shipping
Investigation Overview
Nothing Is Billed Unless You Are Prescribed
TelePeptide's payment model deserves to be copied:"$0 today. Billed only if prescribed. Your card is authorized at intake — a temporary hold, not a charge — and nothing is billed unless a clinician issues a prescription. If you're prescribed, the clinician consultation fee is already included in the program price shown above, never charged separately. If you're not prescribed, you pay nothing at all."Compare that to the common pattern in this category: pay for a "consultation" first, discover eligibility second. TelePeptide removes the financial incentive to approve everyone, which is the structural problem underneath a lot of what we criticise elsewhere.
It Publishes What the Trials Actually Found—and What They Did Not
This passage is, frankly, better than what most of the industry manages:"We don't post made-up before-and-afters. We post what was actually measured in published randomized trials of the branded versions of these medications (compounded formulations were not studied). Every figure is published, cited, and traceable — and individual results vary."The figures it then quotes are correct and correctly attributed: mean body-weight reduction with semaglutide 2.4 mg weekly over 68 weeks, and with tirzepatide 15 mg weekly over 72 weeks, plus the proportion of semaglutide patients achieving at least 5% reduction. Crucially it states, in the same breath, that the compounded versions it sells were not the products studied. Set that against EllieMD's "26%+ over 6-8 weeks." Same category, opposite standard of care with the truth.
Pricing Is Published in Full
"No quote forms. No 'contact sales.' Every program, every tier, every price is published. All-inclusive — clinician, medication, shipping." Programs run $89/month to $249/month, all-inclusive of clinician evaluation, prescription, medication and shipping, with flat monthly billing and cancel-anytime terms. Products include compounded semaglutide and tirzepatide weekly injections, a semaglutide plus naltrexone dissolvable tablet, sub-therapeutic GLP-1 combination tracks, sermorelin and NAD+.Corporate Structure Is Disclosed
TelePeptide states that clinical services are provided by a contracted multi-state medical group, that "TelePeptide LLC does not itself practice medicine and does not employ the prescribing clinicians," and that the medical group's identity is available on request. Every prescription is issued by a clinician licensed in the patient's state. That structure — a marketing entity contracting with a professional corporation — is standard across telehealth and almost never explained. Disclosing it is the right call.Where We Would Still Push Back
Microdosing. TelePeptide sells "sub-therapeutic GLP-1 combos" on a gradual-titration track "targeting metabolic health rather than rapid weight loss." Sub-therapeutic means below the doses that produced the trial results. There is no evidence base for microdosed GLP-1s, and TelePeptide's careful language does not change that. Oral dissolvable tablets. A semaglutide plus naltrexone dissolvable tablet has no published absorption or dosing evidence, the same problem we have flagged at The Wellness Company and elsewhere. Sermorelin and NAD+. TelePeptide describes sermorelin as "a synthetic GHRH analog historically used in clinical evaluation," which is a notably hedged phrasing, and says whether either is clinically appropriate is a clinician's call. The hedging is honest; the products still sit outside evidence-based practice. PCOS. Explicitly labelled off-label, which is the correct disclosure. Coverage. 48 states plus DC — Alaska and Mississippi are not served.Our Investigation Summary
Our research (August 8, 2026) found TelePeptide practising a standard of disclosure that is rare in this category. It publishes every program price ($89 to $249/month, all-inclusive of clinician, medication and shipping) with no quote forms; it authorises your card at intake as a hold rather than a charge and bills nothing at all if a clinician does not prescribe, which removes the financial incentive to approve everyone; and it states explicitly that it does not post fabricated before-and-after photos, quoting instead correctly attributed trial figures for semaglutide 2.4 mg over 68 weeks and tirzepatide 15 mg over 72 weeks while noting in the same passage that "compounded formulations were not studied." It also discloses its corporate structure — that TelePeptide LLC does not practise medicine or employ the prescribing clinicians, that clinical services come from a contracted multi-state medical group whose identity is available on request, and that every prescription is issued by a clinician licensed in the patient's state. Service covers 48 states plus DC, excluding Alaska and Mississippi, with 503A/503B pharmacies and typical 3-5 day shipping. Our reservations concern the product menu rather than the conduct: sub-therapeutic "microdose" GLP-1 tracks have no evidence base, an oral semaglutide-plus-naltrexone dissolvable tablet has no published absorption or dosing data, and sermorelin and NAD+ sit outside evidence-based practice even with TelePeptide's carefully hedged descriptions. PCOS use is correctly labelled off-label.
How TelePeptide Works
Complete a short intake — about ten minutes, with no payment and no commitment required
Your card is authorised as a temporary hold at intake, not charged
A licensed clinician reviews your intake, typically within 48 hours, by chart review or live audio/video consult depending on your state's telemedicine law
If a clinician does not prescribe, you pay nothing at all
If prescribed, your program price includes the clinician consultation — never billed separately
Medication is compounded by a licensed 503A or 503B pharmacy and shipped, typically within 3-5 days
Flat monthly billing with cancel-anytime terms, plus 24/7 messaging with your care team
What We Found
What's Good
- Charges nothing at all if a clinician does not prescribe — card is held, not billed
- Publishes every program and price ($89-$249/month) with no quote forms or sales gates
- All-inclusive pricing covers clinician, medication and shipping in one flat monthly figure
- Explicitly refuses to post fabricated before-and-after photos
- Quotes correctly attributed trial figures and states that compounded formulations were not studied
- Discloses that TelePeptide LLC does not practise medicine or employ the prescribing clinicians
- Names the state exclusions up front rather than at checkout
- Every prescription issued by a clinician licensed in the patient's state
- Uses licensed 503A and 503B pharmacies
- Labels PCOS use as off-label
- 24/7 care team messaging, cancel anytime
Watch Out For
- Sells sub-therapeutic 'microdose' GLP-1 tracks with no supporting evidence base
- Offers an oral semaglutide-plus-naltrexone dissolvable tablet with no published absorption or dosing data
- Sells sermorelin and NAD+ therapy, which sit outside evidence-based practice
- Not available in Alaska or Mississippi
- The contracted medical group is named only on request rather than published
- Compounded medications are not FDA-approved for safety, effectiveness or quality
- Direct-pay only — no insurance accepted
Pricing Breakdown
Safety & Medical Oversight
Customer Support
Key Features
Best For
Anyone who wants to know the full price before starting and does not want to pay for a consultation that might not result in a prescription — provided you stick to the standard-dose injectable programs rather than the microdose or oral tracks
Customer Reviews & Complaints
We assessed TelePeptide against its published material as of August 8, 2026, where the notable finding is how much it publishes.
What we verified directly: service in 48 states plus DC with Alaska and Mississippi excluded; published pricing from $89 to $249/month, all-inclusive; a card-hold-not-charge intake with nothing billed absent a prescription; clinician review typically within 48 hours; 3-5 day shipping; 503A/503B pharmacies; off-label labelling for PCOS; and an explicit statement that TelePeptide LLC does not practise medicine and does not employ the prescribing clinicians.
The evidence disclosure is the standout. TelePeptide writes: "We don't post made-up before-and-afters. We post what was actually measured in published randomized trials of the branded versions of these medications (compounded formulations were not studied)." The figures it then presents — semaglutide 2.4 mg over 68 weeks, tirzepatide 15 mg over 72 weeks, and the share of semaglutide patients reaching at least 5% reduction — match the published trial results and are attributed to the correct products and durations. Almost nothing else in this category does this.
Where we would still push back: a company this careful about trial evidence also sells sub-therapeutic microdose combinations, an oral dissolvable tablet and sermorelin — three product lines with no comparable evidence behind them. The disclosure standard and the product menu are not fully consistent with each other.
What we could not establish: founding year, headquarters, the identity of the contracted medical group (available on request but not published), independent third-party review data, or refund terms beyond cancel-anytime.
Is TelePeptide Legit?
"Is TelePeptide legitimate?" Our assessment as of August 8, 2026.
Official Verification: TelePeptide states that clinical services are delivered by a contracted multi-state medical group of state-licensed clinicians, that every prescription is issued by a clinician licensed in the patient's state, and that medications are compounded by licensed 503A and 503B pharmacies. It publishes a state coverage list and a providers page. We found no evidence of wrongdoing.
The billing model is the strongest signal of good faith. A company that only gets paid when a clinician prescribes has an obvious incentive to prescribe. A company that charges nothing when no prescription is issued has removed the fee that would otherwise reward approving everyone — but note that it still earns nothing from a decline, so the incentive is not fully neutral either. What matters is that the patient does not lose money finding out they are not eligible, which is exactly backwards at many competitors.
The evidence disclosure sets the benchmark. Stating that the compounded product you sell was not the product studied is commercially inconvenient and factually necessary. We have criticised several companies in this comparison for doing the opposite; consistency requires crediting the one that gets it right.
The product menu is where our rating stops short of the disclosure quality. Microdosing, oral dissolvable tablets and sermorelin are all sold with careful language and no evidence. Careful language about an unevidenced product is better than reckless language, but it is not the same as evidence.
Red Flags Check:
- ✓ Nothing billed unless a clinician prescribes
- ✓ Every program and price published, no sales gates
- ✓ Refuses fabricated before-and-after imagery
- ✓ Trial figures correctly attributed, with compounded caveat stated
- ✓ Corporate structure disclosed — LLC does not practise medicine
- ✓ State exclusions published up front
- ✓ 503A/503B pharmacies; clinician licensed in your state
- ✓ Off-label uses labelled as off-label
- ⚠ Sub-therapeutic microdose tracks have no evidence base
- ⚠ Oral dissolvable tablet has no absorption or dosing data
- ⚠ Sermorelin and NAD+ sit outside evidence-based practice
- ⚠ Medical group named only on request
The Bottom Line: On conduct — pricing, billing, evidence, corporate disclosure — this is among the best-behaved operators we have reviewed, and the "billed only if prescribed" model is one we would like to see become standard. On products, stick to the standard-dose injectable semaglutide or tirzepatide programs, where the trial evidence TelePeptide cites honestly actually applies. Skip the microdose tracks, the dissolvable tablets and the peptides. As always, consult your personal physician before starting any new medication program.
Our Verdict: Under Watch
After our comprehensive investigation, TelePeptide receives a 7.9/10 rating. While this provider meets basic standards, there are some areas for improvement. Consider comparing with our top-rated options before making a decision.
Visit TelePeptideCoreAge Rx
Our highest-rated GLP-1 weight loss program
TelePeptide
$89-$249/month all-inclusive — clinician, medication and shipping
Investigation Summary
Share Your Experience
Help others by sharing your experience with TelePeptide
Want to compare options?
View All 195 ProvidersUser Reviews
No ratings yet
Rate your experience
Click a star to rate and add a review
Questions & Discussions
Explore Other Reviews
Compare with other GLP-1 weight loss providers we've investigated
Our Top Picks
Mochi Health
Affordable GLP-1 Access Starting at $99/Month with No Long-Term Commitment
Ro
The Brand-Name GLP-1 Route: FDA-Approved Medications Only, with Insurance Concierge Support
More Provider Reviews
CoreAge Rx
Mochi Health
Remedy Meds
Ready to Get Started with TelePeptide?
Review our findings above and make an informed decision about TelePeptide.
Enter to Win a $1,788 CoreAge Rx Gift Card
Enter for a chance to use it toward eligible CoreAge Rx products and services.
The gift card may be applied toward eligible CoreAge Rx products and services. Prescription products additionally require completing the intake process and evaluation by a licensed healthcare provider, who alone decides eligibility and treatment. Winning does not guarantee that you will qualify for a GLP-1 medication or any other prescription treatment.